Class
Description
Onset and Duration
Indications
Contraindications
Adverse Reactions
Drug Interactions
How Supplied
Dosage and Administration
Special Considerations
Antidysrhvthmic (class Ib)
Lidocaine decreases phase-4 diastolic depolarization and suppresses premature ventricular contractions. In addition, it is used to treat ventricular tachycardia and some cases of ventricular fibrillation. Lidocaine also raises the ventricular fibrillation threshold.
Acute ventricular dysrhythmias
Hypersensitivity
Stokes-Adams syndrome
Second- or third-degree heart block in the absence of an artificial pacemaker
Lightheadedness
Confusion
Blurred vision
Hypotension
Cardiovascular collapse
Bradycardia
CNS depression (altered level of consciousness, irritability, muscle twitching, seizures) with high doses
Metabolic clearance of lidocaine may be decreased in patients taking beta-adrenergic blockers or in patients with liver dysfunction. Apnea induced witll succinylcholine may be prolonged with large doses of lidocaine. Cardiac depression may occur if lidocaine is given concomitantly with IV phenytoin. Additive neurological effects may occur with procainamide.
Pregnancy safety: Category B.
Therapeutic plasma levels of lidocaine between 2-6 mcg/ml suppress ventricular dysrhythmias. A 75- to 100-mg bolus maintains adequate blood levels for only 20 min. If bradycardia occurs in conjunction with PVCs, always treat the bradycardia first with atropine, isoproterenol, or both. Exceedingly high doses of lidocaine can result in coma or death. Avoid lidocaine for reperfusion dysrhythmias after thrombolytic therapy.